|
Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab
|
Dec 2014
|
Blood
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
The myelodysplastic syndrome as a prototypical epigenetic disease.
|
May 2013
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes
|
Apr 2019
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party
|
Apr 2012
|
Blood
|
aplastic anemia
|
|
Genetics of Progression From MDS to Secondary Leukemia
|
Jul 2020
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.
|
Aug 2013
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Mutational hierarchies in myelodysplastic syndromes dynamically adapt and evolve upon therapy response and failure
|
Jun 2016
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion
|
Dec 2015
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
How we treat higher-risk myelodysplastic syndromes
|
Dec 2013
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
How I treat acquired aplastic anemia
|
Jan 2012
|
Blood
|
aplastic anemia
|
